In addition to its effect on cancer, miR-301a is shown to play an important role in regulating the expression of Kv4.2 in diabetes [56] and controlling autoimmune demyelination by regulating the T-helper 17 immune response [57]. Here, KCND2 is linked to diabetes mellitus.